세계의 간헐성 파행 시장 보고서(2025년)

Intermittent Claudication Global Market Report 2025

US $ 4,490 ￦ 6,183,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,938,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,692,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

간헐성 파행 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 2029년에는 연간 평균 성장률(CAGR) 6.2%로 성장할 전망이며, 173억 9,000만 달러로 성장이 예측됩니다. 예측 기간 동안 성장은 당뇨병 유병률 증가, 비만율 상승, 심혈관 질환 유병률 증가, 알코올 및 담배 소비량 증가, 헬스케어 지출 증가와 같은 요인에 기인하고 있습니다. 예측 기간 주요 동향으로는 PAD 진단의 진보, 웨어러블 디바이스 통합, 맞춤형 의료의 도입, 약제 용출 스텐트로의 시프트, 줄기세포 치료의 진보 등을 들 수 있습니다.

말초동맥질환(PAD)의 이환율 상승은 향후 수년간 간헐성 점진 시장의 성장을 견인할 것으로 예측됩니다. PAD는 동맥이 좁아지면서 손발의 혈류가 감소해 통증이나 저림 등의 합병증을 일으키는 순환기계 질환입니다. PAD 증례의 증가는 고령화, 당뇨병, 흡연, 고혈압, 비만, 앉기 쉬운 라이프 스타일 등의 요인과 관련되어 있습니다. PAD는 운동 시 다리 근육으로의 혈류를 제한하여 산소 부족으로 인한 통증과 경련을 일으킵니다. 2023년 6월에 발행된 미국심장협회 잡지에 따르면 PAD는 미국에서 700만-1,200만 명, 세계에서 2억 명에게 영향을 미치고 있습니다. 이 PAD의 유병률 증가가 간헐성 파행 시장의 확대를 촉진하고 있습니다.

간헐성 파행 시장의 기업은 말초 동맥 질환 및 간헐성 파행 환자의 치료 성적을 개선하기 위해 RIPK1 억제제와 같은 고급 약물 요법의 개발에 주력하고 있습니다. 이러한 치료제는 혈류를 촉진하고 염증을 억제하며 질병 진행을 예방하는 것을 목표로 합니다. RIPK1 억제제는 RIPK1 키나아제 활성을 억제하는 표적 약물이며 염증과 세포 사멸을 억제합니다. 2022년 8월, 중국에 본사를 두고 있는 생명공학 기업인 GenFleet사는 간헐성 파행을 이용한 PAD의 신규 치료제 GFH312의 2상 임상시험을 실시하는 승인을 미국 식품의약국(FDA)으로부터 취득했습니다. 이 무작위화, 이중 맹검, 위약 대조 시험은 15개의 연구센터에서 실시됩니다. GFH312는 RIPK1 억제제이며 전임상시험에서 동물 모델의 염증을 억제함으로써 유망한 결과를 보여줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 간헐성 파행 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 간헐성 파행 시장 : 성장률 분석
• 세계의 간헐성 파행 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 간헐성 파행 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 간헐성 파행 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 간헐성 파행 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 약물 요법
• 혈행 재건술
• 세계의 간헐성 파행 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 비경구 경로
• 경구 경로
• 기타 투여 경로
• 세계의 간헐성 파행 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 클리닉
• 재택 헬스케어
• 기타 용도
• 세계의 간헐성 파행 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 간헐성 파행 시장 : 약물 요법 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 항혈소판제
• 혈관확장제
• 포스포디에스테라아제 억제제
• 실로스타졸
• 펜톡시필린
• 세계의 간헐성 파행 시장 : 혈행 재건술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 혈관 성형술
• 스텐트 유치술
• 바이패스 수술
• 동맥내막 절제술

제7장 지역별 및 국가별 분석

• 세계의 간헐성 파행 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 간헐성 파행 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 간헐성 파행 시장 : 경쟁 구도
• 간헐성 파행 시장 : 기업 프로파일
  • Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Bristol Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
  • AstraZeneca PLC : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
  • GSK plc : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Eli Lilly and Company
• Merck KGaA
• Teva Pharmaceutical
• Otsuka Pharmaceutical Co. Ltd.
• Sanofi SA
• Bayer AG
• Hikma Pharmaceuticals PLC
• Dr. Reddy's Laboratories
• Pipelinepharma
• Pharmaoffer
• Alkem Laboratories
• LGM Pharma
• Aastrid Life Sciences Pvt. Ltd.
• Manus Aktteva Biopharma LLP
• Enomark Pharma

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 간헐성 파행 시장(2029년) : 새로운 기회를 제공하는 국가
• 간헐성 파행 시장(2029년) : 새로운 기회를 제공하는 부문
• 간헐성 파행 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Intermittent claudication is a condition marked by muscle pain, cramping, or discomfort in the legs that occurs during physical activity, such as walking, and is relieved by rest. It is usually caused by peripheral artery disease (PAD), which occurs when narrowed or blocked arteries restrict blood flow to the muscles. The pain is typically due to a lack of oxygen (ischemia) in the affected muscles.

The primary treatments for intermittent claudication include medication therapies and revascularization procedures. Medication therapies involve the use of drugs to relieve symptoms, improve blood flow, reduce pain, and prevent complications related to poor circulation. These medications are administered through various methods, such as parenteral, oral, and other routes, and are used in settings such as hospitals, clinics, and home healthcare. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The intermittent claudication market research report is one of a series of new reports from The Business Research Company that provides intermittent claudication market statistics, including the intermittent claudication industry's global market size, regional shares, competitors with a intermittent claudication market share, detailed intermittent claudication market segments, market trends and opportunities, and any further data you may need to thrive in the intermittent claudication industry. This intermittent claudication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intermittent claudication market size has grown strongly in recent years. It will grow from $12.81 billion in 2024 to $13.64 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to factors such as the rise in peripheral artery disease, increased awareness of vascular diseases, growth in the geriatric population, higher diagnosis rates, and an increase in healthcare spending.

The intermittent claudication market size is expected to see strong growth in the next few years. It will grow to $17.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of diabetes, rising obesity rates, growing prevalence of cardiovascular diseases, higher alcohol and tobacco consumption, and increasing healthcare spending. Key trends in the forecast period include advancements in PAD diagnostics, the integration of wearable devices, the incorporation of personalized medicine, a shift toward drug-eluting stents, and progress in stem cell therapy.

The rising incidence of peripheral artery disease (PAD) is expected to drive the growth of the intermittent claudication market in the coming years. PAD is a circulatory condition where narrowed arteries reduce blood flow to the limbs, causing pain, numbness, and other complications. The increasing number of PAD cases is linked to factors such as an aging population, diabetes, smoking, hypertension, obesity, and sedentary lifestyles. PAD leads to intermittent claudication by limiting blood flow to the leg muscles during physical activity, resulting in pain and cramping due to a lack of oxygen. According to the American Heart Association Journals, published in June 2023, PAD affects 7 to 12 million people in the U.S. and 200 million people worldwide. This growing prevalence of PAD is driving the expansion of the intermittent claudication market.

Companies in the intermittent claudication market are focusing on developing advanced medication therapies, such as RIPK1 inhibitors, to improve treatment outcomes for patients with peripheral artery disease and intermittent claudication. These therapies aim to enhance blood flow, reduce inflammation, and prevent disease progression. RIPK1 inhibitors are targeted drugs that block RIPK1 kinase activity, which helps reduce inflammation and cell death. In August 2022, GenFleet, a biotechnology company based in China, received approval from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial for GFH312, a new treatment for PAD with intermittent claudication. This randomized, double-blind, placebo-controlled study will take place at 15 research centers. GFH312 is a RIPK1 inhibitor that has shown promising results in preclinical studies by reducing inflammation in animal models.

In April 2023, Abbott Laboratories, a healthcare company based in the U.S., acquired Cardiovascular Systems Inc. for $890 million. This acquisition is aimed at expanding Abbott's vascular device portfolio by incorporating Cardiovascular Systems Inc.'s advanced technologies for treating peripheral and coronary artery disease. The acquisition strengthens Abbott's position in the cardiovascular market and improves patient care with innovative, minimally invasive solutions. Cardiovascular Systems Inc. is a U.S.-based medical device company known for its innovative treatments for peripheral artery disease, including intermittent claudication.

Major players in the intermittent claudication market are Pfizer Inc., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GSK plc, Eli Lilly and Company, Merck KGaA, Teva Pharmaceutical, Otsuka Pharmaceutical Co. Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, Pipelinepharma, Pharmaoffer, Alkem Laboratories, LGM Pharma, Aastrid Life Sciences Pvt. Ltd., Manus Aktteva Biopharma LLP, Enomark Pharma, and Pharmacompass.

North America was the largest region in the intermittent claudication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intermittent claudication report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intermittent claudication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intermittent claudication market includes revenues earned by entities by providing services such as non-invasive tests, angioplasty, stent placement, supervised exercise therapy, and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The intermittent claudication market also consists of sales of antiplatelet agents, statins, vasodilators, and special socks or stockings. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intermittent Claudication Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intermittent claudication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intermittent claudication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intermittent claudication market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Medication Therapies; Revascularization
• 2) By Route Of Administration: Parenteral Route; Oral Route; Other Routes Of Administration
• 3) By Application: Hospitals; Clinics; Home Healthcare; Other Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Medication Therapies: Antiplatelet Agents; Vasodilators; Phosphodiesterase Inhibitors; Cilostazol; Pentoxifylline
• 2) By Revascularization: Angioplasty; Stenting; Bypass Surgery; Endarterectomy
• Companies Mentioned: Pfizer Inc.; Bristol Myers Squibb Company; AstraZeneca PLC; Novartis AG; GSK plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intermittent Claudication Market Characteristics

3. Intermittent Claudication Market Trends And Strategies

4. Intermittent Claudication Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Intermittent Claudication Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intermittent Claudication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intermittent Claudication Market Growth Rate Analysis
• 5.4. Global Intermittent Claudication Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intermittent Claudication Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intermittent Claudication Total Addressable Market (TAM)

6. Intermittent Claudication Market Segmentation

• 6.1. Global Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication Therapies
• Revascularization
• 6.2. Global Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral Route
• Oral Route
• Other Routes Of Administration
• 6.3. Global Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Healthcare
• Other Applications
• 6.4. Global Intermittent Claudication Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Intermittent Claudication Market, Sub-Segmentation Of Medication Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiplatelet Agents
• Vasodilators
• Phosphodiesterase Inhibitors
• Cilostazol
• Pentoxifylline
• 6.6. Global Intermittent Claudication Market, Sub-Segmentation Of Revascularization, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Angioplasty
• Stenting
• Bypass Surgery
• Endarterectomy

7. Intermittent Claudication Market Regional And Country Analysis

• 7.1. Global Intermittent Claudication Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intermittent Claudication Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intermittent Claudication Market

• 8.1. Asia-Pacific Intermittent Claudication Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intermittent Claudication Market

• 9.1. China Intermittent Claudication Market Overview
• 9.2. China Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intermittent Claudication Market

• 10.1. India Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intermittent Claudication Market

• 11.1. Japan Intermittent Claudication Market Overview
• 11.2. Japan Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intermittent Claudication Market

• 12.1. Australia Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intermittent Claudication Market

• 13.1. Indonesia Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intermittent Claudication Market

• 14.1. South Korea Intermittent Claudication Market Overview
• 14.2. South Korea Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intermittent Claudication Market

• 15.1. Western Europe Intermittent Claudication Market Overview
• 15.2. Western Europe Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intermittent Claudication Market

• 16.1. UK Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intermittent Claudication Market

• 17.1. Germany Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intermittent Claudication Market

• 18.1. France Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intermittent Claudication Market

• 19.1. Italy Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intermittent Claudication Market

• 20.1. Spain Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intermittent Claudication Market

• 21.1. Eastern Europe Intermittent Claudication Market Overview
• 21.2. Eastern Europe Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intermittent Claudication Market

• 22.1. Russia Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intermittent Claudication Market

• 23.1. North America Intermittent Claudication Market Overview
• 23.2. North America Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intermittent Claudication Market

• 24.1. USA Intermittent Claudication Market Overview
• 24.2. USA Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intermittent Claudication Market

• 25.1. Canada Intermittent Claudication Market Overview
• 25.2. Canada Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intermittent Claudication Market

• 26.1. South America Intermittent Claudication Market Overview
• 26.2. South America Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intermittent Claudication Market

• 27.1. Brazil Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intermittent Claudication Market

• 28.1. Middle East Intermittent Claudication Market Overview
• 28.2. Middle East Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intermittent Claudication Market

• 29.1. Africa Intermittent Claudication Market Overview
• 29.2. Africa Intermittent Claudication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intermittent Claudication Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intermittent Claudication Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intermittent Claudication Market Competitive Landscape And Company Profiles

• 30.1. Intermittent Claudication Market Competitive Landscape
• 30.2. Intermittent Claudication Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

31. Intermittent Claudication Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Merck KGaA
• 31.3. Teva Pharmaceutical
• 31.4. Otsuka Pharmaceutical Co. Ltd.
• 31.5. Sanofi S.A.
• 31.6. Bayer AG
• 31.7. Hikma Pharmaceuticals PLC
• 31.8. Dr. Reddy's Laboratories
• 31.9. Pipelinepharma
• 31.10. Pharmaoffer
• 31.11. Alkem Laboratories
• 31.12. LGM Pharma
• 31.13. Aastrid Life Sciences Pvt. Ltd.
• 31.14. Manus Aktteva Biopharma LLP
• 31.15. Enomark Pharma

32. Global Intermittent Claudication Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intermittent Claudication Market

34. Recent Developments In The Intermittent Claudication Market

35. Intermittent Claudication Market High Potential Countries, Segments and Strategies

• 35.1 Intermittent Claudication Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intermittent Claudication Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intermittent Claudication Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료